Robotic platforms for endometrial cancer treatment: review of the literature
Citation
Gungorduk K, Kahramanoglu O, Ozdemir IA, Kahramanoglu I. Robotic platforms for endometrial cancer treatment: review of the literature. Minerva Med. 2021 Feb;112(1):47-54. doi: 10.23736/S0026-4806.20.07053-6. PMID: 33586397.Abstract
Introduction: The cornerstone in the management of endometrial cancer (EC) is surgical staging. Over the last few decades, minimally invasive surgery has been widely accepted as a mainstay in the treatment of endometrial cancer. The first robotic-assisted gynecological surgery was performed in 1998.
Evidence acquisition: The literature search was conducted using MEDLINE, EMBASE and PUBMED databases from January 1998 to September 2020.
Evidence synthesis: Several studies have reported the advantages of robotic-assisted surgery over laparoscopy in the management of EC. These are most pronounced in obese patients. Robotic-assisted surgery is also associated with a shorter learning curve, particularly for lymphadenectomy, which enables more surgeons to perform minimally invasive surgery for EC.
Conclusions: The effectiveness and oncological results of robotic surgery for EC appear to be similar to those of other surgical methods, but fewer intraoperative complications occur than with other methods.

















